← FDA Drug Approvals (Drugs@FDA)

LUPKYNIS

NDA · New Drug Application · Sponsor: AURINIA · Approved 2021-01-22

Drug application

FDA Application #

NDA213716

Application type

New Drug Application

Brand name

LUPKYNIS

Generic name

VOCLOSPORIN

Active ingredients

VOCLOSPORIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AURINIA

Manufacturer

Aurinia Pharma U.S., Inc.

First approval

2021-01-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown